Novo Nordisk Infographic

Novo Nordisk Stock Falls

Barron's on MSN · 2d

Novo Nordisk Is Falling. Compeitition Is a Killer.

Roche agreed to develop a weight-loss drug with Danish biotech Zealand Pharma, pressuring Novo Nordisk and Eli Lilly.

MarketWatch on MSN · 2d

Roche takes big step in weight-loss field with $5.3 billion deal. Novo Nordisk shares fall.

Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to Zealand Pharma in a licensing and development deal.

Wall Street Journal · 2d

Novo Nordisk Stock Falls After Roche Strikes Weight-Loss Deal

Swiss pharmaceutical company Roche struck a multibillion-dollar collaboration and licensing deal with Zealand Pharma to co-develop a weight-loss treatment. Shares in Roche rallied in Europe, while Zealand stock surged around 30%.

1don MSN

Novo Nordisk rebounds as Kepler upgrades Ozempic maker at long last

Novo Nordisk (NVO) stock rebounds after Kepler Cheuvreux upgrades to Buy following a 42% stock drop over the past year. Read ...

1don MSN

How a Novo Nordisk Foundation-funded project sparked ultra-processed food fight

The Novo Nordisk Foundation and University of Copenhagen researchers have backtracked over a project to redefine how the ...

Yahoo Finance9d

Novo Nordisk Plunges 21% in 3 Months: Buy, Sell or Hold the Stock?

Novo Nordisk NVO shares have lost 21% in the past three months against the industry’s growth of 4.6%. The company has also underperformed in the sector and the S&P 500 during the same time frame ...

Novo Nordisk Skeptic Finally Upgrades Stock After Drop From Peak

A long-term Novo Nordisk A/S skeptic recommended buying shares of the Danish weight-loss drug maker nine years after starting ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results